NIH Guide: Weekly Index for May 1, 2020

Funding Opportunities

• Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)
  (PA-20-070)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Applications are due by May 29, 2020 by 5:00 PM local time of applicant organization.
• Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional)
  (PA-20-072)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Applications are due by May 29, 2020 by 5:00 PM local time of applicant organization.
• Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)
  (PAR-20-177)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Applications will be accepted on a rolling basis, beginning on 04/30/2020 .
• Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
  (PAR-20-178)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Applications will be accepted on a rolling basis, beginning on 04/30/2020 .
• Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)
  (PAR-20-179)
  Office of Disease Prevention
  National Institute on Aging
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 05, 2020.
• Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)
  (PAR-20-180)
  Office of Disease Prevention
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 05, 2020.
• Coordinating Unit to Support the Kidney, Urology and Hematology (KUH) Innovative Science Accelerator Program (ISAC-CU) (U24 Clinical Trial Not Allowed)
  (RFA-DK-20-010)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): August 4, 2020
• U.S. - India Collaborative Environmental Health Research Program (R01 Clinical Trial Optional)
  (RFA-ES-20-010)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): October 15, 2020
• Superfund Research Program Occupational Health and Safety Education Programs on Emerging Technologies (R25 - Clinical Trial Not Allowed)
  (RFA-ES-20-011)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): August 3, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC) Disease Modifying Therapies for Chronic Lung Diseases (U24 Clinical Trial Required - Infrastructure)
  (RFA-HL-21-012)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): July 24, 2020 by 5:00 PM local time of applicant organization.
• Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)
  (RFA-HL-21-013)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): July 24, 2020, March 19, 2021, June 1, 2022. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.